Prognostic impact of pretreatment C-reactive protein for patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors

By Yasuda Yosuke   Saito Kazutaka   Yuasa Takeshi   Kitsukawa Shinichi   Urakami Shinji   Yamamoto Shinya   Yonese Junji   Takahashi Shunji   Fukui Iwao  

International Journal of Clinical Oncology, Vol. 18, Iss. 5, 2013-10 ,pp. : 884-889

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic significance of C-reactive protein in patients with intermediate-risk metastatic renal cell carcinoma treated with molecular targeted therapy

By                            

Oncology Letters, Vol. 8, Iss. 2, 2014-01 ,pp. : 881-885

Spandidos Publications

Access to resources Recommend Favorite

Predictors of outcome for EGFR-mutant non-small-cell lung cancer treated with first-line tyrosine kinase inhibitors

By Pilotto Sara   Bria Emilio  

Lung Cancer Management, Vol. 2, Iss. 2, 2013-04 ,pp. : 89-92

Future Medicine

Access to resources Recommend Favorite

Predicting outcome to VEGF-targeted therapy in metastatic clear-cell renal cell carcinoma: data from recent studies

By Golshayan Ali-Reza   Brick Ashley J   Choueiri Toni K  

Future Oncology, Vol. 4, Iss. 1, 2008-02 ,pp. : 85-92

Future Medicine

Access to resources Recommend Favorite

Comparison of Survival Rates in Patients with Metastatic Renal Cell Carcinoma According to Treatment Era Including Cytokine and Targeted Therapy

By Takagi Toshio   Kondo Tsunenori   Kennoki Takafumi   Iizuka Jyunpei   Kobayashi Hirohito   Hashimoto Yasunobu   Tanabe Kazunari  

Japanese Journal of Clinical Oncology, Vol. 43, Iss. 4, 2013-04 ,pp. : 439-443

Oxford University Press

Access to resources Recommend Favorite